文献速递中药与中成药合理使用中医内科

基于分子对接虚拟筛选抗COVID-19潜在中药

In Silico Screening of Potential Chinese Herbal Medicine Against COVID-19 by Targeting SARS-CoV-2 3CLpro and Angiotensin Converting Enzyme II Using Molecular Docking.
PubMed 文献 · Chin J Integr Med · 2020-07-06

研究采用分子对接技术,将中药成分与SARS-CoV-2 3CL水解酶和ACE2受体对接,虚拟筛选抗COVID-19潜在中药。共筛选238种潜在抗COVID-19中药,发现6个小分子化合物与两靶标结合能最优,16种中药含活性成分最多,5种高频候选中药,并确定连翘-金银花为核心药对。结论认为该药对含多成分多靶点,易与3CLpro和ACE2结合,通过多成分多靶点多途径发挥抗COVID-19肺炎作用。

要点

  • 连翘-金银花药对可能通过多成分多靶点抑制SARS-CoV-2 3CLpro和ACE2。
  • 虚拟筛选出238种潜在抗COVID-19中药,其中16种含活性成分最多。
  • 6个小分子化合物与3CLpro和ACE2结合能最优,5种中药高频使用。

核心结论

  • 连翘-金银花核心药对含多成分多靶点,易与3CLpro和ACE2结合,通过多成分多靶点多途径发挥抗COVID-19肺炎作用。

研究设计与样本

  • 采用Autodock Vina软件进行分子对接,靶点为SARS-CoV-2 3CL水解酶和ACE2。
  • 从TCMSP数据库检索作用于3CLpro和ACE2受体的中药单体,筛选活性成分并推测关键中药和化合物。
  • 基于网络药理学构建化学-靶点网络,用DAVID进行GO功能富集和KEGG通路富集分析推测核心药对作用机制。

主要发现

  • 6个小分子化合物与两个靶标蛋白具有最优结合能。
  • 共筛选238种潜在抗COVID-19中药,其中16种含活性成分最多,5种为高频使用的候选抗COVID-19中药。
  • 确定核心药对为连翘-金银花(Forsythiae Fructus-Lonicerae Japonicae Flos)。

临床怎么用

  • 连翘-金银花药对可作为抗COVID-19肺炎的候选中药组合,但需进一步实验验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To seek potential Chinese herbal medicine (CHM) for the treatment of coronavirus disease 2019 (COVID-19) through the molecular docking of the medicine with SARS-CoV-2 3CL hydrolytic enzyme and the angiotensin converting enzyme II(ACE2) as receptors, using computer virtual screening technique, so as to provide a basis for combination forecasting. METHODS: The molecular docking of CHM with the SARS-Cov-2 3CL hydrolase and the ACE2 converting enzyme, which were taken as the targets, was achieved by the Autodock Vina software. The CHM monomers acting on 3CLpro and ACE2 receptors were retrieved from the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform, the active ingredients were selected, and the key CHMs and compounds were speculated. Based on the perspective of network pharmacology, the chemical-target network was constructed, and the functional enrichment analysis of gene ontology and the pathway enrichment analysis of Kyoto encyclopedia of genes and genomes were carried out by DAVID to speculate about the mechanism of action of the core drug pairs. RESULTS: There are 6 small molecule compounds that have the optimal binding energy with the two target proteins. Among 238 potential anti-COVID-19 herbs screened in total, 16 kinds of CHM containing the most active ingredients, and 5 candidate anti-COVID-19 herbs that had been used in high frequency, as well as a core drug pair, namely, Forsythiae Fructus-Lonicerae Japonicae Flos were selected. CONCLUSION: The core drug pair of Forsythiae Fructus-Lonicerae Japonicae Flos containing multiple components and targets is easy to combine with 3CLpro and ACE2, and exerts an anti-COVID-19 pneumonia effect through multi-component and multi-target, and plays the role of anti-COVID-19 pneumonia in multi-pathway.

来源:Chin J Integr Med,查看原文。版权归原作者所有。

引用

  1. Gao LQ, Xu J, Chen SD, et al. In Silico Screening of Potential Chinese Herbal Medicine Against COVID-19 by Targeting SARS-CoV-2 3CLpro and Angiotensin Converting Enzyme II Using Molecular Docking. Chin J Integr Med. 2020. PMID: 32632717. doi:10.1007/s11655-020-3476-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。